Literature DB >> 27702476

Production of steviol from steviol glucosides using β-glycosidase from Sulfolobus solfataricus.

Thi Thanh Hanh Nguyen1, Seong-Bo Kim2, Nahyun M Kim3, Choongil Kang4, Byoungsang Chung4, Jun-Seong Park5, Doman Kim6.   

Abstract

Steviol is a diterpene isolated from the plant Stevia rebaudiana that has a potential role as an antihyperglycemic agent by stimulating insulin secretion from pancreatic beta cells and also has significant potential to diminish the renal clearance of anionic drugs and their metabolites. In this study, the lacS gene, which encodes a thermostable β-glycosidase (SSbgly) enzyme from the extremely thermoacidophillic archaeon Sulfolobus solfataricus, was cloned and expressed in E. coli Rossetta BL21(DE3)pLyS using lactose as an inducer. Through fermentation, SSbgly was expressed as a 61kDa protein with activity of 24.3U/mg and the OD600 of 23 was reached after 18h induction with 10mM lactose. Purified protein was obtained by Ni-Sepharose chromatography with a yield of 92.3%. SSbgly hydrolyzed steviol glycosides to produce steviol with a yield of 99.2%. The optimum conditions for steviol production were 50U/ml SSbgly and 90mg/ml Ste at 75°C as determined by the response surface method.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Optimization; Steviol; Stevioside; Sulfolobus solfataricus; β-glycosidase

Mesh:

Substances:

Year:  2016        PMID: 27702476     DOI: 10.1016/j.enzmictec.2016.08.013

Source DB:  PubMed          Journal:  Enzyme Microb Technol        ISSN: 0141-0229            Impact factor:   3.493


  2 in total

Review 1.  Status of the application of exogenous enzyme technology for the development of natural plant resources.

Authors:  Bin Yuan; Shiyu Zhou; Changwei Liu; Sheng Zhang; Jiayin Li; Ailing Liu
Journal:  Bioprocess Biosyst Eng       Date:  2020-11-04       Impact factor: 3.210

2.  Improved conversion of ginsenoside Rb1 to compound K by semi-rational design of Sulfolobus solfataricus β-glycosidase.

Authors:  Kyung-Chul Shin; Hye-Yeon Choi; Min-Ju Seo; Deok-Kun Oh
Journal:  AMB Express       Date:  2017-10-04       Impact factor: 3.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.